[Linux] 73171 FOR IMMEDIATE RELEASE (fwd)

---------

New Message Reply About this list Date view Thread view Subject view Author view

From: Mustafa Akgul (akgul@Bilkent.EDU.TR)
Date: Fri 12 Jul 2002 - 05:23:15 EEST


Date: Thu, 11 Jul 2002 19:14:14 -0700 (PDT)
From: HPCwire <hpcwire@tgc.com>
Message-Id: <200207120214.TAA64346@newsmaster.tgc.com>
To: akgul@Bilkent.EDU.TR
Subject: 73171 FOR IMMEDIATE RELEASE
X-Virus-Scanned: by AMaViS snapshot-20010714

FOR IMMEDIATE RELEASE
CONTACT:
Brad Rutledge
Linux NetworX
801-562-1010 ext. 218
brutledge@linuxnetworx.com

Boehringer Ingelheim Pharmaceuticals Uses Linux NetworX Cluster
                 to Aid in Drug Discovery
Linux Cluster Helps Pharmaceutical Company Improve Efficiency and Save Time

SALT LAKE CITY, UTAH, April 2, 2002 ¾ Linux NetworX announced today that
Boehringer Ingelheim Pharmaceuticals, Inc. is advancing its human healthcare
research and development processes with a 120-processor Linux NetworX
EvolocityT cluster supercomputer. The Ridgefield, Conn. laboratory of
Boehringer Ingelheim Pharmaceuticals is using the cluster supercomputer to
help predict the suitability of certain molecules in potential drugs. This
process is ideal for a Linux cluster supercomputer because the same compute
process is completed for hundreds of thousands of molecules. Computational
chemists and biologists at Boehringer Ingelheim Pharmaceuticals are also
using the cluster to run applications to find the best combinations of
molecules and protein binding sites for drug development.

 "With a 120-processor cluster, managing every aspect of the system
 can be quite overwhelming," said Dave Craska, lead systems engineer
 for Boehringer Ingelheim Pharmaceuticals, Inc. "The ClusterWorX
 software from Linux NetworX helps alleviate the complexities of
 cluster management, especially when upgrading and propagating new
 releases of software."
 Before switching to a Linux NetworX cluster, scientists at
 Boehringer Ingelheim Pharmaceuticals were running the same
 applications on a variety of systems, but results were slowed
 because of the limited number of available CPUs. After deploying the
 Linux NetworX cluster, information was processed quickly and
 efficiently, saving Boehringer Ingelheim Pharmaceuticals time and
 money.

The massive amount of data computation inherent in drug design typically
requires the power of a supercomputer class system. Cluster technology is a
method of linking multiple computers, or compute nodes, together to form a
powerful, unified system. Linux NetworX clusters can match the performance
of traditional supercomputers for a fraction of the cost.
-more-

Page 2 of 2 - Boehringer Ingelheim Pharmaceuticals uses Linux NetworX
Cluster For Drug Development

"The bioinformatics industry is experiencing an enormous demand for
cost-effective, reliable supercomputing solutions and many pharmaceutical
companies are turning to Linux clusters to meet that need," said Clark
Roundy, vice president of marketing at Linux NetworX. "Companies such as
Boehringer Ingelheim Pharmaceuticals demand quick, accurate results and
Linux NetworX provides the management tools to ensure our customers focus on
their core competencies instead of system management."
Boehringer Ingelheim Pharmaceuticals' Evolocity system includes 120 Pentium
III 866 MHz processors, 50 GB of memory, an Intel 10/100 NIC connection and
ClusterWorX cluster management software. To ensure optimum cluster
operation, Boehringer Ingelheim Pharmaceuticals also signed a service and
support contract with Linux NetworX.

About Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is
the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield,
CT) and a member of the Boehringer Ingelheim group of companies. The
Boehringer Ingelheim group of companies, with headquarters in Ingelheim
(Germany) is one of the 20 leading pharmaceutical firms in the world and
reported revenues of almost US $5.8 billion in 2000. Boehringer Ingelheim,
which has some 140 affiliated companies worldwide, focuses on human
pharmaceuticals and animal health. The human pharmaceuticals business, which
accounts for 95% of sales, is comprised of prescription medicines, consumer
health care products and chemicals and biopharmaceuticals for industrial
customers . Research and development, production, and distribution
facilities are located around the globe. In 2000, Boehringer Ingelheim spent
almost US $914 million on R&D, equivalent to 15.6% of net sales.

For more information on Boehringer Ingelheim, please see the international
Internet website www.boehringer-ingelheim.com

About Linux NetworX
Linux NetworX (www.linuxnetworx.com) brings its powerful and easy-to-manage
cluster technology to those demanding high performance and high availability
systems. Linux NetworX provides solutions for organizations involved in oil
and gas exploration, aeronautical and chemical modeling, biotechnology
research, graphics rendering and visual effects, Web serving, ISPs, ASPs,
and other technological research fields. Through its innovative Evolocity
hardware, ICET cluster management tools and professional service and
support, Linux NetworX provides end-to-end clustering solutions. To date,
the company has built some of the largest cluster systems in the world, and
boasts numerous Fortune 500 customers.

###

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Anthony May 8445 Camino
Santa Fe
Senior Account Executive, HPCwire San Diego, CA 92121
anthony@hpcwire.com PH (858) 625-0070
http://tgc.com/hpcwire/ FAX (858) 625-0088

           T A B O R G R I F F I N C O M M U N I C A T I O N S
          ---------------------------------------------------------
              HPCwire DSstar INTERNET PUBLISHING SOLUTIONS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

****************************************************************************
HPCwire has released all copyright restrictions for this item. Please feel
free to distribute this article to your friends and colleagues. For a free
trial subscription, send e-mail to trial@hpcwire.tgc.com.

-----------------------------------------------------------------------
Liste üyeliğiniz ile ilgili her türlü işlem için
http://liste.linux.org.tr adresindeki web arayüzünü kullanabilirsiniz.

Listeden çıkmak için: 'linux-request@linux.org.tr' adresine,
"Konu" kısmında "unsubscribe" yazan bir e-posta gönderiniz.
-----------------------------------------------------------------------


New Message Reply About this list Date view Thread view Subject view Author view

---------

Bu arsiv hypermail 2b29 tarafindan uretilmistir.